ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ABL - US0028241000 - Common Stock
106.04 EUR
-0.3 (-0.28%)
We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making ABL a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, ABL is valued expensive at the moment. These ratings would make ABL suitable for quality investing!
1. Profitability
1.1 Basic Checks
- ABL had positive earnings in the past year.
- ABL had a positive operating cash flow in the past year.
- ABL had positive earnings in each of the past 5 years.
- ABL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 16.60%, ABL belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
- The Return On Equity of ABL (27.43%) is better than 97.06% of its industry peers.
- ABL's Return On Invested Capital of 9.90% is fine compared to the rest of the industry. ABL outperforms 77.94% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
- With an excellent Profit Margin value of 31.88%, ABL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- ABL's Profit Margin has improved in the last couple of years.
- ABL has a better Operating Margin (18.29%) than 75.00% of its industry peers.
- In the last couple of years the Operating Margin of ABL has grown nicely.
- The Gross Margin of ABL (56.19%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
- The number of shares outstanding for ABL remains at a similar level compared to 1 year ago.
- ABL has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
- ABL has an Altman-Z score of 5.68. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of ABL (5.68) is better than 89.71% of its industry peers.
- ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- The Debt to FCF ratio of ABL (1.87) is better than 80.88% of its industry peers.
- ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.23, ABL is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.68 |
ROIC/WACC1
WACC9.89%
2.3 Liquidity
- A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
- ABL's Current ratio of 1.70 is in line compared to the rest of the industry. ABL outperforms 52.94% of its industry peers.
- A Quick Ratio of 1.24 indicates that ABL should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.24, ABL is in line with its industry, outperforming 57.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.40% over the past year.
- The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
- ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.37%.
- ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.63% yearly.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
- ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.68% yearly.
- The Revenue is expected to grow by 7.22% on average over the next years.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 24.72 indicates a rather expensive valuation of ABL.
- 70.59% of the companies in the same industry are more expensive than ABL, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.47. ABL is around the same levels.
- A Price/Forward Earnings ratio of 21.50 indicates a rather expensive valuation of ABL.
- The rest of the industry has a similar Price/Forward Earnings ratio as ABL.
- ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.26.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 21.5 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 61.76% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.99 | ||
| EV/EBITDA | 19.72 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)2.16
PEG (5Y)3.26
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.04%.
- Compared to an average industry Dividend Yield of 1.13, ABL pays a bit more dividend than its industry peers.
- ABL's Dividend Yield is comparable with the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- ABL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
FRA:ABL (1/16/2026, 7:00:00 PM)
106.04
-0.3 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-22 2026-01-22/amc
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap184.39B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target125.19 (18.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
Yearly Dividend1.91
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-0.21%
PT rev (3m)0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.72 | ||
| Fwd PE | 21.5 | ||
| P/S | 4.89 | ||
| P/FCF | 30.99 | ||
| P/OCF | 23.5 | ||
| P/B | 4.21 | ||
| P/tB | 10.02 | ||
| EV/EBITDA | 19.72 |
EPS(TTM)4.29
EY4.05%
EPS(NY)4.93
Fwd EY4.65%
FCF(TTM)3.42
FCFY3.23%
OCF(TTM)4.51
OCFY4.25%
SpS21.69
BVpS25.21
TBVpS10.58
PEG (NY)2.16
PEG (5Y)3.26
Graham Number49.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.68 |
F-Score7
WACC9.89%
ROIC/WACC1
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Overvalued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 24.72 and the Price/Book (PB) ratio is 4.21.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 28.93%.